Affect dysregulation and Dissociation in Substance Use Disorder patients with comorbid Borderline Personality Disorder or Post Traumatic Stress Disorder.

Affect dysregulation and Dissociation in Substance Use Disorder patients with comorbid Borderline Personality Disorder or Post Traumatic Stress Disorder. - Affect dysregulation and dissociation in SUD BPD or SUD PTSD

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON38696

Enrollment

150

Registered

2014-03-12

Start date

2014-03-26

Completion date

Unknown

Last updated

2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Addiction BPD Emotion regulation problems PTSD Trauma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: BPD SUD patients: • Patients between 18 - 60 years, referred to Bouman GGZ • Diagnosis of borderline personality disorder, confirmed by BPD-SI interview • Diagnosis of a substance use disorder (alcohol or drugs), confirmed by a clinical interview • Willing to participate in this project • Abstinent for alcohol or drugs by at least one week • Understand Dutch language;PTSD patients: Same criteria as BPD SUD patients, except diagnosis of BPD. Instead, diagnosis of PTSD, confirmed by ZIL and VBE self-report lists.;SUD patients: • Patients between 18-60 years, referred to Bouman GGZ • Diagnosis of substance use disorder (alcohol and/or drugs), confirmed by a clinical interview • Willing to participate in this project • Abstinent for alcohol or drugs by at least one week • Understand Dutch language • Absence of DSM-IV borderline personality disorder, confirmed by BPD-SI interview • Absence of DSM-IV PTSD, confirmed by ZIL and VBE.

Exclusion criteria

Exclusion criteria: • Cognitive or mental impairments that make self-reports impossible • Instable somatic illness that make self-reports impossible. • Low intelligence • Suicidality: severe suicide ideation or suicide planning

Design outcomes

Primary

Measure	Time frame
A significant difference in overregulation will be expected between BPD SUD en BPD patients and a significant difference in dissociation between PTSD SUD and PTSD patients. Borderline classification will be determined with the BPD-SI. PTSD classification will be determined with the ZIL and VBE. Alcohol or drugs addiction will be measured with a clinical Interview and severity with the Europ-ASI, section III. Dissociation will be measured with the DES and SDQ.	—

Measure

Time frame

A significant difference in overregulation will be expected between BPD SUD en BPD patients and a significant difference in dissociation between PTSD SUD and PTSD patients. Borderline classification will be determined with the BPD-SI. PTSD classification will be determined with the ZIL and VBE. Alcohol or drugs addiction will be measured with a clinical Interview and severity with the Europ-ASI, section III. Dissociation will be measured with the DES and SDQ.

—

Secondary

Measure	Time frame
Dissociation will be measured with the DES and SDQ. The NLV will be administered to exclude low intelligence. Affect Dysregulation which will be measured with the EI\/IOV-56 and with the SIDES rev-sr.	—

Countries

Netherlands

Outcome results